Adams et al., "Electron-Affinic Sensitization," Radiation Research, 67, 9-20 (1976). |
Andrade et al., "Inhibitore of Nitric Oxide Synthase Selectively Reduce Flow in Tumor-Associated Neovasculature," Br. J. Pharmacol., 107, 1092-1095 (1992). |
Bedford et al., "Threshold Hypoxia: Its Effect on the Survival of Mammalian Cells Irradiated at High and Low Dose-Rates," Br. J. Radiol., 39, 896-900 (1966). |
Bohn et al., "Oxygen and Oxidation Promote the Release of Nitric Oxide fron Sydnonimines," Journal of Cardiovascular Pharmacology, 14(Suppl. 11), s6-s12 (1989). |
Coleman et al., "Phase I Trial of the Hypoxic Cell Radiosensitizer SR-2508: The Results of the Five to Six Week Drug Schedule," I.J. Radiation Oncology Biol. Phys., 12, 1105-1108 (1986). |
DeGraff et al., "Evaluation of Nitroimidazole Hypoxic Cell Radiosensitizers in a Human Tumor Cell Line High in Intracellular Glutathione," I.J. Radiation Oncology Biol. Phys., 16, 1021-1024 (1989). |
Feelisch et al., "On the Mechanism of NO Release from Sydnonimines," Journal of Cardiovascular Pharmacology, 14(Suppl. 11), s13-s22 (1989). |
Feelisch, M., "The Biochemical Pathways of NItric Oxide Formation from Nitrovasodilators: Appropriate Choice of Exogenous NO Donars and Aspects of Preparation and Handling of Aqueous NO Solutions," J. Cardiovasc. Pharmacol., 17(Suppl. 3), s25-s33 (1991). |
Gatenby et al., "Oxygen Distribution inSquamous Cell Carcinoma Metastases and its Relationship to Outcome of Radiation Therapy," I.J. Radiation Oncology Biol. Phys., 14, 831-838 (1988). |
Hall et a., "Extreme Hypoxia: Its Effect on the Survival of Mammalian Cells Irradiated at High and Low Dose-Rates," Br. J. Radiol., 39, 302-307 (1966). |
Hall, Eric J., "The Oxygen Effect and Reoxygenation," Radiobiology for the Radiologist, 4.sup.th Ed., 133-164 (1994). |
Howard-Flanders, "Effect of Nitric Oxide on the Radiosensitivity of Bacteria," Nature, 180, 1191-1192 (1957). |
Hrabie et al., "New Nitric Oxide-Releasing Zwitterions Derived form Polyamines," J. Org. Chem, 58, 1472-1476 (1993). |
Ignarro Louis J., "Biosynthesis and Metabolism of Endothelium-Derived Nitric Oxide," Annu. Rev. Pharmacol. Texicol, 30, 535-560 (1990). |
Keefer et al., "Complexes of Nitric Oxide with Nucleophiles as Agents for the Controlled Biological Release of Nitric Oxide," Biology of Nitric Oxide, 2, Enzymology, Biochemistry, Immunology, pp. 153-156, Moncada et al., eds. Portland Press, Chapel Hill, NC (1992). |
Maragos et al., "Complexes of NO with Nucleophiles as Agents for the Controlled Biological Release of Nitric Oxide," J. Med. Chem., 34, 3242-3247 (1991). |
Maragos et al., "Nitric Oxide/Nucleophile Complexes Inhibit the In Vitro Proliferation of A375 Melanoma Cells via Nitric Oxide Release," Cancer Research, 53, 564-568 (1993). |
Mitchell et al. "Cellular Glutathione by Diethyl Meleate or Buthionine Sulfoximine: No Effect of Glutathione Depletion on the Oxygen Enhancement Ratio," Radiation Research, 96, 442-428 (1983). |
Mitchell et al., "Radiation Sensitisation by Nitric Oxide Releasing Agents," British Journal of Cancer, 74(Suppl. 27), s181-s184 (1996). |
Morley et al., "Mechanism of Vascular Relaxation Induced by the Nitric Oxide (NO)/Nucleophile Complexes, a New Class of NO-Based Vasodilators," Journal of Cardiovascular Pharmacology, 21, 670-676 (1993). |
Murayama et al., "Radiosensitization of Hypoxic HeLa S3 Cells In Vitro by a New Type of Radiosensitizer: Spermine and Spermidine amides with Nitro Groups," Int. J. Radiat. Biol., 44(5), 497-503 (1983). |
Phillips et al., "Promise of Radiosensitizers and Radioprotectors in the Treatment of Human Cancer," Cancer Treatment Reports, 68(1), 291-302 (1984). |
Phillips et al., "Variation in Sensitizing Efficiency for SR 2508 in Human Cells Dependent on Glutathione Content," I.J. Radiation Oncology Biol. Phys., 12, 1627-1635 (1986). |
Powers-Tolmach, "A Mulitcomponent X-Ray Survival Curve for Mouse Lymphosarcoma Cells Irradiated In Vivo," Nature, 197, 710-711 (1963). |
Russo et al., "The Effects of Cellular Glutathione Elevation on the Oxygen Enhancement Ratio," Radiation Reseach, 103, 232-239 (1985). |
Siemann et al., "Characterization of Radiation Resistant Hypoxic Cell Subpopulations in KHT Sarcomas. (ii) Cell Sorting," Br. J. Cancer, 58, 296-300 (1988). |
Song et al., Int. J. Rad. Oncol. Biol. Phys., 30(Suppl. 1), 208 (1994). |
Stamler et al., "S-Nitrosylation of Proteins with Nitric Oxide: Synthesis and Characterization of Biologically Active Compounds," Proc. Natl. Acad. Sci. USA, 89, 444-448 (1992). |
Stamler et al., "Nitric Oxide Circulates an Mammalian Plasma as an S-Nitroso Adduct of Serum Albumin," British Journal of Cancer, IV(4), 7476-7677 (1992). |
Thomlinson et al., "The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy," British Journal of Cancer, IV(4), 539-549 (1955). |
Von Sonntag, C., "The Chemical Basis of Radiation Biology," The Chemical Basis of Radiation Biology, Taylor and Francic, eds., London(1987). |
Wink et al., "DNA Deaminating Ability and Genotoxicity of Nitric Oxide and its Progenitors," Science, 254, 1001-1003 (1991). |
Wood et al., "Modification of Energy Metabolism and Radiation Response of a Mutrine Tumour by Changes in Nitric Oxide Availability," Biochemical and Biophysical Research Communications, 192(2), 505-510 (1993). |